Creative Medical Technology Holdings (CELZ) Tax Rate (2018 - 2025)
Creative Medical Technology Holdings' (CELZ) quarterly Tax Rate came in at 65.28% in Q4 2025, down 473.0% year-over-year from 17.5% in Q4 2024, and down 7.81% quarter-over-quarter from 60.56% in Q4 2024.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) Tax Rate (2018 - 2025) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Tax Rate for 5 consecutive years, with 65.28% the latest figure, recorded in Q4 2025.
- On a quarterly basis, Tax Rate fell 473.0% year-over-year to 65.28% in Q4 2025; TTM through Jun 2026 was 20.41%, a 93.0% decrease from a year earlier, with the FY2025 full-year figure at 20.56%, down 12.0% from the prior year.
- Tax Rate was 65.28% for Q4 2025 at Creative Medical Technology Holdings, down from 60.56% in the prior quarter.
- Over five years, Tax Rate peaked at 60.56% in Q4 2024 and troughed at 65.28% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 17.12% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -1.11% |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 2.88% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -40.18% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -2.32% |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -179.59% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Creative Medical Technology Holdings | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -65.28% |
| Dec 31, 2024 | -60.56% |
| Dec 31, 2020 | -0.65% |
| Dec 31, 2019 | -5.25% |
| Dec 31, 2018 | 12.85% |